Figure 2.
A. Survival curves for high and low PDGFβR positive stroma fraction. Kaplan-Meier graph shows worse overall survival for high PDGFβR positive stroma fraction as compared to low PDGFβR positive stroma fraction in serous ovarian cancer (n=186 patients) (p=0.012, Log Rank). Median survival for high PDGFβR positive stroma fraction 19.3 months versus 36.8 months for low PDGFβR positive stroma fraction. B. Survival curves for high and low PDGFβR positive perivascular intensity. Kaplan-Meier graph shows worse overall survival for high PDGFβR positive perivascular intensity as compared to low PDGFβR positive perivascular intensity, in 186 patients (p=0.005, Log Rank). Median survival for high PDGFβR positive perivascular intensity was 20.4 months versus 45.3 months for low PDGFβR positive perivascular intensity.